Summary:
In this podcast, Pharma and Drug Delivery executives from Novartis, AstraZeneca, Merck and Quotient Sciences discuss traditional and novel approaches to improve the oral delivery of peptides including:- The biopharmaceutics of oral peptide and the use of permeation enhancers
- Alternate sites for the delivery of oral peptides throughout the GI tract
- Improving oral exposure through ingestible devices
- Delivering ASOs and other large synthetics
- Next-generation approaches for delivery
This presentation was recorded at the October 2024 PODD: Partnership Opportunities in Drug Delivery conference. For more information, go to Drug-Delivery.org.
Moderators
Lipa Shah, PhD
Director Science and Technology, Drug Development/Pharmaceutical Development
Novartis
Panelists
Annette Bak, PhD, MBA
Head of Advanced Drug Delivery
AstraZeneca
Suman Luthra, PhD
Director | Discovery Pharmaceutical Sciences
Merck
Andy Lewis, PhD
Chief Scientific Officer
Quotient Sciences
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.